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Abstract
Objective—To determine the prevalence, etiologies, and risk factors of blindness and visual
impairment among persons age 40 years and older residing in an urban West African location.
Design—Population-based cross-sectional study.
Participants—Five thousand six hundred and three participants residing in Tema, Ghana.
Methods—Proportionate random cluster sampling was used to select participants age 40 and
over living in the city of Tema. Presenting distance visual acuity was measured at 4 and 1 meters
using a reduced Logarithm of the Minimum Angle of Resolution (logMAR) tumbling E chart and
then with trial frame based on autorefraction. A screening examination was performed in the field
on all participants. Complete clinical examination by an ophthalmologist was performed on
participants with best corrected visual acuity < 20/40 or failure of any screening test.
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Main Outcome Measures—Age- and gender-specific prevalence, causes, and risk factors for
blindness (visual acuity in the better eye of < 20/400, World Health Organization definition) and
visual impairment (visual acuity in the better eye of < 20/40).
Results—Six thousand eight hundred and six eligible participants were identified of which 5603
(82.3%) participated in the study. The mean age (±standard deviation) of participants was
52.7±10.9. The prevalence of visual impairment was 17.1% and blindness was 1.2%. After
refraction and spectacle correction, the prevalence of visual impairment and blindness decreased
to 6.7% and 0.75% respectively, suggesting that refractive error is the major correctable etiology
of visual impairment and blindness in this population. Of 65 subjects having visual acuity <
20/400, 22 (34%) were correctable with refraction, 21 to the level of visual impairment, and one to
normal. The remaining 43 (66%) had underlying pathology (19 cataract, 9 glaucoma, 3 non-
glaucomatous optic neuropathy, 3 corneal opacities, 3 retinal disease, 5 undetermined) that
prevented refractive correction. Increased age was a significant risk factor for blindness and visual
impairment.
Conclusions—There is a high prevalence of blindness and visual impairment among those aged
≥40 years in Tema, Ghana, West Africa. Refractive error is a major cause of blindness and visual
impairment in this population, followed by cataract, glaucoma, and corneal disease.
INTRODUCTION
Sub-Saharan Africa bears a disproportionate amount of the world’s blindness1, 2 and the
proportion of people blind in this region is increasing at a faster rate than in other parts of
the world.1, 2 Ghana is a country of approximately 24 million people3 located in West
Africa. It currently is in the middle stages of a demographic transition typical of many
developing countries in Africa, from a high birth rate and short life expectancy to a lower
birth rate and increased longevity.4 Part of this demographic transition is driven by a shift
from a primarily rural agrarian society (where high birth rates yield economic rewards) to an
urban society (where high birth rates have the opposite effect).5 The percentage of Ghana’s
population that lives in urban areas has more than doubled in the past 50 years, from 23% in
1960 to 48% in 2009.6 Chronic eye diseases such as cataract and glaucoma may represent a
greater percentage of disease burden today because of the reduced prevalence of infectious
causes of blindness such as trachoma and onchocerciasis from improvements in their
prevention and treatment as well as population shifts away from endemic regions,1,7 and
increased life expectancy in developing West African countries such as Ghana.8 In addition,
improvements in economic status and urbanization have led to increased obesity9 and
diabetes mellitus prevalence10 in Ghana and other developing African countries and the
prevalence of diabetic eye disease and its impact on vision in this population is unknown.
The paucity of country-specific data regarding the prevalence of blindness and visual
impairment in Africa led the World Health Organization (WHO) in 2004 to recommend
additional study of the prevalence and etiologies of visual impairment in sub-Saharan
Africa.1 The purpose of this portion of the Tema Eye Survey (TES) was to determine the
age-specific prevalence and etiologies of, and factors associated with, blindness and visual
impairment in an urban West African population.
METHODS
Study Population
Tema is a city of the Greater Accra Region in Ghana, West Africa. Approximately 17.6%
percent of Ghana’s population lives in the Greater Accra Region,11, 12 despite the fact that
this is the geographically smallest of Ghana’s 10 regions. The 2005 estimated population in
the Tema District was 562,291, extrapolated from census data from 200012 and known birth
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and death rates. As one of the busiest ports in West Africa, Tema has attracted workers from
all over Ghana, making it an ethnically and economically diverse environment for study; for
these reasons Tema was chosen for the current survey.
Tema is divided into 20 communities. Five of these communities were selected for study
based on their ethnic diversity and lower socioeconomic status. These included: Community
1, Ashiaman Southeast, Ashiaman Southwest, Bethlehem/Kakasunanka, and Tema
Newtown. These communities are further divided into polling stations by the Ghanaian
government for the purpose of voting and represent distinct geographic areas (analogous to
neighborhoods). We used voting rolls, which contained the number (but not names) of
voting-age individuals and the name of each polling station, to divide the communities into
clusters. With the help of local polling officials (usually a local teacher or government
official), the polling stations were mapped in each of the five communities selected. A
sample size of 5,600 was calculated using the National Center for Health Statistics (NCHS)
standards to specifically determine the prevalence of glaucoma in subjects age 40 or over.
The NCHS standard for a reliable prevalence estimate is one that has a Relative Standard
Error (RSE) of less than or equal to 30%.13
A random cluster sampling strategy with probability of cluster selection proportionate to
size of the community under study was used to obtain a representative sample and avoid
bias. Each polling station of more than 350 voting-age adults in each of the five
communities was eligible for inclusion. Large polling stations (greater than 600 voting-age
adults) were broken down into smaller clusters of 350 – 600 voting-age individuals.
Population data from the 2000 census for Ghana12 indicated that 38% voting-age individuals
are age 40 or over while 62% are between ages 18 and 39 years. It was estimated that 190
subjects would be of an eligible age per cluster. Polling stations with fewer than 350 voting-
age adults were excluded because these small areas would be expected to yield too few
subjects age 40 and over. The number of clusters selected from each of the five communities
varied based on the total estimated eligible population in each community, creating a
proportional cluster sampling of the population. All eligible clusters within each community
were placed in a random number generator and ordered based on the random number order
from lowest to highest. A house-to-house census was conducted in each randomly selected
cluster and residents age 40 and over were invited to participate in a screening eye
examination (field examination) as part of a study. They were given an appointment card
with a specific appointment date and time for the following week and asked to bring their
glasses with them.
Field Examination
Field examinations were conducted in schools or churches within subjects’ communities
near their homes. After the identity, address, and eligibility of each subject was confirmed,
written informed consent was obtained. An extensive health questionnaire was taken orally
in the subject’s native language. Subjects then underwent a screening examination that
included testing of presenting visual acuity using the reduced logMAR (logarithm of the
minimum angle of resolution) tumbling E chart13 at 4 meters and then at 1 meter if they
were unable to see any letters at 4 meters. This vision chart provides a close approximation
of Early Treatment Diabetic Retinopathy Study (ETDRS) vision but is designed specifically
for countries with low literacy rates. Autorefraction (Humphrey Autorefractor model 599,
Carl Zeiss Meditec, Dublin, CA, USA) was then performed if the presenting visual acuity
(VA) was < 20/40 and the visual acuity was rechecked with a trial frame correction using
the autorefraction results. Frequency Doubling Technology perimetry (FDT, Carl Zeiss
Meditec, Dublin, CA, USA), intraocular pressure with Tonopen XL (Reichert Ophthalmic
Instruments, Depew, NY), ultrasonic pachymetry (DGH, Exton, PA, USA), flashlight
screening for potentially occludable anterior chamber angles,14 and dilated optic disc and
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macular photographs using a handheld digital fundus camera (Kowa Genesis D, Kowa
Company, Ltd, Tokyo, Japan) were then performed. Neither slit lamp examination nor
gonioscopy were performed in the field examination. Presenting visual acuity was defined
by the visual acuity obtained in the field with the subject’s distance glasses on. The field
examinations were performed by study personnel from the Unites States (US) or United
Kingdom (UK), local ophthalmic nurses, and local ophthalmic technicians. An intensive
three week training period was performed by three of the investigators (DLB, KB, WN) on
the correct protocol for obtaining informed consent, data collection, field examinations, and
use of equipment prior to the study. During this training period, two separate two-day field
examination sessions were performed at a church and a mosque in a nearby community that
was not part of the study. Subjects who tested positive on any screening tests were referred
back to the clinic for complete ophthalmic examination by study investigators for the
purpose of training on clinic procedures and to address the medical reasons for positive tests.
Criteria for Referral to Clinic
Subjects were referred to clinic for complete examination for the following reasons: Best
corrected visual acuity worse than 6/12 (20/40) after spectacle correction based on
autorefraction; more than one abnormal spot on the FDT Screening C20-5 program on two
tests in either eye; intraocular pressure ≥ 21 mmHg on the average of two readings; narrow
anterior chamber by flashlight testing by ophthalmic nurse; abnormal optic disc or macular
photographs as assessed by the Moorfields Eye Hospital Reading Centre. Subjects who were
not able to be tested with the FDT screening mode or in whom photographs were not
possible were referred to clinic for complete examination.
Clinic Examination
Clinic examinations consisted of manifest refraction by a licensed optometrist followed by
measurement of best corrected visual acuity (BCVA) using the reduced logMAR tumbling E
chart at 4 meters then at 1 meter if the subject was unable to see any letter on the chart at 4
meters. Next, automated static perimetry was performed using the Humphrey Visual Field
Analyzer 2 with the 24-2 Swedish Interactive Threshold Algorithm (Carl Zeiss Meditec,
Dublin, CA) using the subject’s best correction with age-appropriate presbyopic correction.
All visual fields were uploaded to a secure study website and evaluated by one of the study
investigators (JWdV). An investigator/ophthalmologist then performed a complete dilated
ophthalmic examination including Goldmann applanation tonometry, gonioscopy, and
fundus examination. Lastly, simultaneous stereoscopic optic disc and macular photographs
were performed using the Nidek 3Dx camera (Nidek Co., Ltd., Gamagori, Japan). These
were uploaded to a secure study website and evaluated in a masked fashion by the
Moorfields Eye Hospital Reading Centre, London, UK. BCVA was defined by the visual
acuity in the better eye following manifest refraction by the optometrist in the clinic. Visual
data is presented for presenting and best corrected vision at the time of presentation, before
any intervention, such as cataract surgery. Subjects with visually significant cataracts were
referred to the ophthalmologist at the Tema Christian Eye Center for free cataract surgery
and referred back to the study clinic for completion of the dilated examination by a study
ophthalmologist and posterior segment photographs. Subjects with closed or occludable
anterior chamber angles were referred for free laser or surgical iridotomy by a study
investigator and then sent back to the study clinic for completion of the dilated examination
and photography. Subjects with glaucoma or other ophthalmic conditions requiring
monitoring or treatment were referred to the Tema Christian Eye Center for evaluation and
management by a local Ghanaian ophthalmologist. Ophthalmologist investigators were
asked to determine the presence or absence of any eye disease(s) and were asked to
determine the primary etiology of the visual impairment.
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Definitions of Blindness and Visual Impairment
This study used the World Health Organization’s definitions of visual impairment and
blindness16 with the addition of a category for Mild Visual Impairment (visual acuity <
20/40 to ≥ 20/60) as suggested by a recent eye survey in Nigeria17 and for comparison with
US definitions.18,19 Moderate Visual Impairment was used for visual acuity < 20/60 but ≥
20/200. Severe Visual Impairment was used for visual acuity < 20/200 but ≥ 20/400. Any
visual impairment was defined as visual acuity < 20/40 but ≥ 20/400. Blindness was
reserved for those with visual acuity < 20/400 or visual field constriction to less than 10°
from fixation. Anyone who had vision of 20/40 or better was classified as Normal/Near
Normal. Data are presented for presenting visual acuity (distance visual acuity in the better
seeing eye with presenting correction prior to autorefraction and without pinhole assistance)
and best corrected visual acuity (distance visual acuity in the better seeing eye after manifest
refraction by an optometrist with correction in trial frame). The cause of blindness and
visual impairment for each subject was based on the World Health Organization
recommendation that the primary cause should be the pathology that is most amenable to
treatment or prevention.
Statistical Analysis
Age-specific prevalences of visual impairment and blindness were calculated by taking the
number of subjects in a specific age group with blindness or visual impairment divided by
the number of individuals who participated in the study in that age group. Factors associated
with blindness and visual impairment were calculated using logistic regression and Mantel-
Haenszel procedures. Statistical analysis was performed using PASW 18.0 (IBM Inc.).
Protection of Human Subjects and Informed Consent
The Ethics Committee of the Ghana Ministry of Health and the individual Institutional
Review Boards of each of the investigators who examined participants approved this study.
The study was conducted in accordance with protection of human subjects guidelines set
forth by the Declaration of Helsinki. All study personnel having contact with subjects were
required to complete CITI (Collaborative Institutional Training Initiative) certification prior
to obtaining informed consent. Each subject signed a written informed consent form
approved by the Ghana Ethics Committee prior to conducting any study-related activity. If
the subject did not read or speak English, the national language of Ghana, a translator was
provided to explain the study and answer questions. On the specific recommendation of the
Ethics Committee of the Ghana Ministry of Health, subjects were paid the equivalent of $2
US for their participation in field examinations and the equivalent of $5 US for their
participation in clinic examinations. If subjects were asked to repeat clinic examinations or
ancillary testing, an additional $5 US was provided. Since the field examinations were
conducted in the communities where subjects resided, no transportation was provided to
field examinations. Transportation to and from the clinic was offered free of charge. Field
examinations were conducted from September 2006 through August 2008 and clinic
examinations continued through December 2008.
RESULTS
There were a total of 230 clusters identified for sampling in the five communities. Thirty
seven of these were randomly chosen, the number of clusters from each community (and
therefore, the number of subjects) proportionate to the estimated number of people age 40
and over residing in each community. The house-to-house census enumerated 6806 eligible
subjects of whom 5,603 came for the field examination for a participation rate of 82.3%.
The field examination identified 1869 (33.3%) subjects who failed one or more screening
Budenz et al. Page 5










examinations. Of these, 1538 came back to the clinic for complete examination by an
ophthalmologist for a participation rate at this stage of 82.2%.
The demographic characteristics of subjects in the Tema Eye Survey are shown in Table 1.
Although 30% of subjects were from the Greater Accra region, 70% were born elsewhere in
Ghana; 7.7% were from outside Ghana, from nearby Mali (40), Togo (37), Nigeria (14), and
Cote d’Ivoire (13). Table 2 presents the distribution of subjects enumerated in the census
and examined in the field by age and gender. In all age ranges, there were more females
enumerated and examined than males and this difference increased with age. There were no
differences, however, in the proportion of males and females enumerated vs. examined,
demonstrating that our sample was representative of the population of this area.
The prevalence of visual impairment and blindness was higher among older participants
(Tables 3 and 4). For the entire group, the prevalence of any visual impairment or blindness
in presenting visual acuity was 18.3% (95% confidence interval, CI, 17.3% – 19.3%). The
prevalence of any visual impairment or blindness based on BCVA was 7.4% (95% CI 6.8%
– 8.1%) indicating that refractive error alone accounted for approximately 60% of the visual
impairment and blindness in this population. The prevalence of blindness, defined as visual
acuity < 20/400 in the better eye, was 1.2% (95% CI 0.9 –1.5%) on presentation and was
reduced to 0.75% (95% CI 0.54% – 1.01%) using BCVA.
Of the 331 subjects who were examined in the field but did not report for the clinic
examination, 63.8% had been referred for failure of FDT, 29.1% for IOP greater than 21
mmHg in either eye, 18.5% for vision less than 20/40, and 4.7% for inability to take fundus
photographs (subjects could have been referred for more than one reason, thus the totals are
greater than 100%). Subjects who failed to come to clinic were younger (54 vs. 60 years, P <
0.001), had worse vision (20/60 vs. 20/50, P < 0.001), and had slightly lower IOP (18
mmHg vs. 19 mmHg, P < 0.001) than those who came to clinic. Eight percent more women
than men failed to come to the clinic examination (P = 0.001).
Sixty-seven subjects had presenting visual acuity < 20/400 of whom 25 were correctable
with refraction so that 21 still had visual impairment and the remaining one had normal VA.
The remaining 42 subjects had underlying pathology that was not correctable with
refraction: 19 cataract, 9 glaucoma, 3 non-glaucomatous optic neuropathy, 3 corneal
opacities, 3 retinal diseases, 5 undetermined (Table 5). There were no definite cases of
blindness from diabetes mellitus or age related macular degeneration identified. Two cases
of corneal opacification were thought to be secondary to trachoma and were in persons aged
68 and 75.
Factors associated with visual impairment (BCVA < 20/40 but ≥ 20/400) and blindness
(BCVA < 20/400 or visual field of < 10°) are shown in Tables 6 and 7 respectively. Older
age and widowed marital status were significantly associated with visual impairment in the
multivariate analysis while age and a prior history of ocular disease were significantly
associated with blindness in the multivariate analysis. Data on socioeconomic status were
not available.
Because we were concerned about using seven ophthalmologists to determine the cause of
visual impairment and blindness, 29 subjects were examined by all investigators in a masked
fashion and the presence and cause of visual impairment or blindness was noted by each.
Investigators agreed that there was no ophthalmic diagnosis in 14 of them and agreed on the
same diagnoses causing visual impairment or blindness in eight. Among the other seven,
there were five patients upon whom the examining ophthalmologists disagreed about a
determination of primary open angle glaucoma versus glaucoma suspect, one in which there
was a disagreement about whether there was chronic narrow angle glaucoma present, and
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one about which there was a disagreement about traumatic glaucoma. However, these did
not affect the presence or absence of visual disability and blindness, just the cause of these
conditions in these few subjects.
DISCUSSION
The Tema Eye Survey is one of only a few population studies of blindness, visual
impairment, and eye diseases in West Africa and perhaps the only one that has studied a
purely urban population. We found a high prevalence of curable vision loss, due to either
uncorrected refractive error or cataract. The percentage of curable visual impairment from
refractive error or cataract was 39.2% and the percentage of curable blindness from these
causes was 58.3%. In addition, preventable vision loss from glaucoma was found to be a
significant problem in this population.
There are several reasons why it is difficult to directly compare blindness prevalence survey
results across studies. First, many different definitions of blindness and visual impairment
have been used in the past. Second, studies vary widely in how they achieve best corrected
vision. The current study used the WHO definition of blindness as presenting distance visual
acuity less than 20/400 and visual impairment of varying degrees from less than 20/60 to
20/400. It also included the category of Mild Visual Impairment (< 20/40 to ≥ 20/60) for
comparison to a recent study in Nigeria16 and to the US definition of visual impairment (<
20/40),17 as evidenced by the legal limits for a driver’s license in most US states.18, 19 The
current study went to great length to provide best corrected vision in subjects by having
them refracted by an optometrist and then retested.
There have been two other population surveys of the prevalence and etiologies of blindness
in Ghana. Both were conducted in rural areas. In the early 1990s, Moll et al20 surveyed 866
subjects age 40 and over residing in 10 villages distant from the onchocerciasis endemic
area around the Black Volta River. They found a 2.4% prevalence of blindness (WHO
definition, VA < 20/400 in better eye) for people age 40 and over. In this study, non-
ophthalmologist observers assessed presenting and pinhole visual acuities without
refraction, slit lamp examination, dilated fundus examination, or standardized diagnostic
criteria for glaucoma. The etiologies of blindness and visual impairment determined by non-
ophthalmologist observers were cataract (62.5%), onchocerciasis (12.5%) and corneal
opacities (8.2%). More recently, Guzek and colleagues21 performed a survey of 2298
subjects age 40 and over in three districts of the rural mid-Volta region of Ghana. Three
ophthalmologists and two optometrists performed refractions and complete dilated eye
examinations. They found a 2.8% prevalence of blindness (VA < 20/400) with the main
etiologies being cataract (53.9%) and glaucoma (20.6%). These investigators did not
comment on corneal blindness and found no definite cases of onchocerciasis and only one
case of possible inactive trachoma. We found two cases of suspected inactive trachoma as
possible causes of corneal blindness. It is possible that there were cases of inactive
onchocerciasis that was misdiagnosed as toxoplasmosis or chorioretinal scarring of
indeterminate etiology.
There have been several other population-based surveys of blindness and eye disease in
West Africa. In the mid 1980s, Faal et al.22 surveyed 8174 people of all ages living in both
urban and rural communities in Gambia. They found a 0.7% prevalence of blindness (VA <
20/400) and a 1.4% prevalence of visual impairment (VA < 20/60). The age-specific
prevalence of blindness and visual impairment in adults age 40 and over were very similar to
those in the current study (Table 8, available at http://aaojournal.org). The three most
common etiologies of blindness were cataract (55%), corneal opacity (20%), and trachoma
(17%). In 1990, Kortlang and colleagues23 surveyed 5871 rural residents of all ages residing
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in Mali and found a 1.7% prevalence of both blindness (VA < 20/400) and visual
impairment (VA < 20/60). Only 719 subjects (12.2%) were, however, age 50 or over. The
most frequent causes of blindness in that study were cataract (69%), trachoma (23%) and
glaucoma (9%). In 1993, Whitworth and associates24 examined 1625 subjects of all ages
residing in six rural villages in Sierra Leone in an area known to be hyperendemic for
onchocerciasis. The prevalence of blindness (VA < 20/200 in better eye) in this population
was 1.3% and visual impairment (VA < 20/60 but > 20/200) 4.3%. Again, the prevalence of
blindness and visual impairment was understandably lower in that study than in ours
because of the lower age of the study population. Not surprisingly, onchocerciasis was the
leading cause of blindness (48%), followed by cataracts (19%), corneal opacity (14.3%), and
glaucoma (9.5%). In 1996 Wilson et al.25 surveyed 10,647 subjects of all ages (2183 age 40
or over) in both rural and urban areas in the northern province of Cameroon. They found a
combined prevalence of blindness (VA < 20/200) of 3.7% for all age groups and 15.9% for
people age 40 or over. The leading causes of blindness in all age groups were cataract
(55%), glaucoma (12%), refractive error (9.7%), and trachoma (7.4%). Most recently, the
Nigerian National Blindness and Visual Impairment Survey17 studied 13,599 subjects age
40 and over. The strength of that survey was that it sampled both rural and urban
communities throughout Nigeria. Using the same definitions for visual impairment and
blindness as our study, the authors found a prevalence of blindness (BCVA < 20/400) of
3.4% and a prevalence of visual impairment (BCVA< 20/40) of 14%. Table 8 (available at
http://aaojournal.org) summarizes the prevalence of visual impairment and blindness in the
current study compared to other prevalence studies performed in Ghana and West Africa.
Table 9 (available at http://aaojournal.org) summarizes the prevalence of blindness and
visual impairment from previous studies that reported age-specific data with an emphasis on
ethnicity. Comparison with previous studies suggests that people of African descent residing
in Africa, the Caribbean, the UK, and the US have higher prevalences of visual impairment
and blindness than other ethnic groups with the exception of Indian Asians, although direct
comparison of these studies is difficult because of the difference between age-specific and
age-adjusted data. Age is the strongest risk factor for eye disease in all epidemiologic studies
and the life expectancy in the US, UK, and Caribbean (mid 70s) is approximately twenty
years higher than in West Africa (mid 50s). The US, UK, and Caribbean populations, which
have a higher percentage surviving to older ages, would thus be expected to have a higher
prevalence of eye diseases, blindness, and visual impairment.
This study has several limitations. Firstly, it would have been ideal to have determined the
prevalence of visual impairment and blindness in people of all ages. However, the
prevalence of eye disease is quite low under age 50 years and the much larger sample size
needed to draw any meaningful conclusions from prevalence data in younger age groups
would have been financially prohibitive. We chose to study people age 40 and over, rather
than 50 and over, to attempt to capture the phenomenon of a younger age of onset of
glaucoma previously reported in people of African descent. The prevalence of glaucoma in
this population will be elucidated and compared to that in non-Africans in a separate report.
A second limitation of this study is that we did not collect data on the prevalence of
blindness and visual impairment in rural Ghana so we cannot generalize the results of the
Tema Eye Survey to the entire country. However, the first population survey of eye disease,
the Baltimore Eye Survey,26 studied only urban-dwelling blacks and whites and these data
have been used to generalize to urban and rural black and white Americans for two decades.
In addition, there have been two population based surveys in rural Ghana20,21 and several in
rural Africa.17, 22–25 Thirdly, because 50% of Ghanaians currently live in urban areas and
increasing urbanization is projected, it made sense to collect blindness and disease
prevalence estimates from an urban setting. Surveying only rural subjects, as done
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previously, may overestimate the prevalence of blindness and visual impairment due to the
high rates of infectious diseases such as trachoma and onchocerciasis and underestimate the
prevalence of chronic diseases such as cataract and glaucoma. We realize that the opposite
phenomenon is a limitation of the current study; namely, that surveying only urban
Ghanaians results in a lower prevalence estimate of trachoma and onchocerciasis. The
Nigerian National survey data17 show the unadjusted blindness prevalence for urban and
rural areas to be 3.8% [95% CI 3.1–4.7%] and 4.5% [95% CI 3.8–4.8%] (p=0.18)
respectively. However, after adjusting for age and sex the relative risk was 1.0.
We considered performing the current survey in 5 or 6 different urban and rural regions of
Ghana and determined that this was not feasible for budgetary and logistical reasons. The
Tema district was chosen partly because of its ethnic diversity. The study population was
quite diverse in that most of the subjects were born in regions outside of the study area. We
recognize, however, that the results may not be generalizable to the rest of Ghana or all of
West Africa, because African populations may be the most genetically diverse in the
world.38–40 Also, environmental factors, as well as gene-environment interactions, may
affect the phenotypic expression of complex diseases such as glaucoma.38–40 On the other
hand, recent genetic studies suggest that at least three prominent West African populations
demonstrate striking “genetic homogeneity”. 41 – 45 These West African ethnic groups are
part of the linguistically similar Niger-Kordofanian “macrofamily”, which covers more of
Africa than any other ethno-linguistic macrofamily and is believed to have expanded to the
west from the current border area of Niger and Cameroon and then to central and southern
Africa. 38, 46, 47 So perhaps generalization of genetically determined eye diseases such as
glaucoma is possible from this study.
A third practical limitation of the current study is that participants were examined by seven
different ophthalmologists rather than by the same ophthalmologist. The ophthalmologists
examining subjects undoubtedly had different diagnostic criteria and might have been biased
towards the disease of their subspecialty. Most of the investigators were comprehensive
ophthalmologists or glaucoma specialists with many years of experience diagnosing anterior
segment, optic nerve and retinal diseases. In addition, most diagnoses, like glaucoma and
retinal diseases, were made based solely on visual fields read by a masked glaucoma
specialist and fundus photographs read by masked readers. Other diagnoses, such as corneal
opacification and cataract, are so obvious that we doubt this influenced the results of the
study. Thus we do not believe this to be much of a limitation. Furthermore using multiple
examiners seemed to be the best approach because of the impracticality of a single
ophthalmologist examining all 5,600 subjects over 2 years and 4 months.
As with virtually all similar population surveys, the Tema Eye Survey had more female than
male participants. There may be several reasons for this. First, more females are available
during weekdays to participate, particularly in developing countries where fewer women
work outside the home. Second, the life expectancy is longer in women than men and, since
most eye surveys study people age 40 and older, it is not surprising that one finds more
female than male participants. In the oldest age group (≥80), for instance, there were 129
women enumerated compared to only 53 men. This simply reflects the earlier age of death
of men compared to women. In addition, the 2010 Ghana census showed that there are
48.7% males compared to 51.3% females of all ages.
The current study chose to sample subjects in poor areas of Tema. This was done to increase
participation rates, as people with middle to upper class incomes typically do not participate
since they have the means and access to good eye care. The effect of this is that most
surveys, like the current one, probably overestimate the prevalence of visual impairment and
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blindness from curable conditions like cataract and preventable blindness from diseases such
as glaucoma.
The current study has implications for preventable visual impairment and blindness in
Ghana and similar developing countries in Sub-Saharan Africa. Firstly, refractive error
represented a significant cause of needless visual impairment in this low income population.
In this study, the prevalence of visual impairment and blindness was reduced from 18.3% to
7.4% with manifest refraction alone. We recognize the fact that these data are based on
presenting visual acuity, which assumes subjects brought their glasses to the field
examination place as instructed. However, one would think that subjects with significant
visual impairment who owned glasses would have worn them on a regular basis, including
walking to our field examination location from their homes. The WHO Vision 2020: Right
to Sight report48 has made the correction of refractive error a priority in their Global
Initiative for the Elimination of Avoidable Blindness because it is so cost effective. The
results of the current study support the need for initiatives to increase the examination rate
and provision of glasses in countries like Ghana.
The second important public health implication of this study is that much of the visual
impairment and blindness in this population is due to chronic, rather than infectious, eye
diseases, primarily cataract and glaucoma. This finding is consistent with the most recent
WHO meta-analysis of causes of blindness and visual impairment worldwide conducted in
2002.1 An updated analysis is due to be published shortly (Rupert Bourne, personal
communication). The current study of 5,600 Africans did not identify any definite cases of
onchocerciasis and found very few cases of trachoma, a legacy of the successful intervention
programs for these disorders conducted over the past 20 years.7 While ongoing efforts are
still needed in these areas, they do not help the 50% or so of people residing in urban areas
of sub-Saharan Africa who have non-infectious eye diseases. With increased urbanization of
this region and improved longevity, developing countries in Africa must recognize the
importance of chronic eye diseases of the elderly, such as cataract and glaucoma. This is
quite different from the causes of blindness and visual impairment found in Caucasian
populations of developed country, where age0-related macular degeneration and diabetic
retinopathy contribute significantly to the burden of blindness. In addition, the current study
argues for renewed focus on the prevention of avoidable blindness in urban populations by
increasing the number of ophthalmologists and improving access to ophthalmic care. Ghana,
for instance, currently has approximately 40 ophthalmologists to care for its 24 million
people, a ratio of approximately one ophthalmologist for every 600,000 people. This
compares with a ratio of at least one ophthalmologist for every 10,000 inhabitants in the
US49 and one for every 41,000 in the UK, 50 which has the lowest number of
ophthalmologists per person of any European country.50 Ministries of health should be
encouraged to direct resources to prevent or cure visual impairment and blindness with
increased rates of general ophthalmic care and cataract surgery, including earlier diagnosis
and appropriate management of glaucoma.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
Demographic Characteristics of Subjects in the Tema Eye Survey
Age (Mean ± SD) 52.7 ± 10.9 years (range 40 – 110)
Gender Male 39.7 %
Female: 60.3 %
Region of Birth* Ashanti – 4.8% (20.3%)
Greater Accra – 29.3% (17.1%)
Eastern – 15.2% (10.0%)
North – 4.4% (9.5%)
Western – 3.9% (10.2%)
Brong Ahafo – 0.6% (9.5%)
Volta – 18.5% (8.1%)
Central – 14.7% (8.1%)
Upper East – 0.3% (4.5%)
Upper West – 0.2% (2.7%)
Other Countries – 7.7%





Previous Eye Examination Yes – 37.8%
No – 61.9%
Unknown – 0.3%
History of Diabetes Mellitus Yes – 4.7%
No- 33.9%
Unknown – 61.4%
History of Systemic Hypertension Yes – 29.1%
No - 31.8%
Unknown – 39.1%
History of Eye Disease Yes - 29.7%
No - 70.3%
*
Approximate percentage of people residing in each of Ghana’s ten regions in 2006 given in parentheses for comparison.
SD - standard deviation
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Table 5
Non-Refractive Causes of Visual Impairment and Blindness in the Tema Eye Survey (Number of subjects and
percentages)
Etiology Visual Impairment* Blindness† Blindness‡
Cataract 198 (53.4%) 19 (44.2%) 20 (43.5%)
Glaucoma 52 (14.0%) 9 (20.9%) 10 (21.7%)
Corneal Opacification 28 (7.5%) 4 (9.3%) 4 (8.7%)
Non glaucomatous Optic Atrophy 9 (2.4%) 3 (7.0%) 3 (6.5%)
Retinal disease§ 26 (7.0%) 3 (7.0%) 4 (8.7%)
Others 14 (3.8%) 0 0
Undetermined/No Show 44 (11.9%) 5 (11.6%) 5 (10.9%)
Total 371 43 46
*
Visual Impairment defined as Best Corrected Visual Acuity < 20/40 but ≥ 20/400 in the better seeing eye
†
Blindness defined as Best Corrected Visual Acuity < 20/400 in the better seeing eye
‡
Blindness defined as Best Corrected Visual Acuity < 20/400 in the better seeing eye or visual field less than 10 %
§
Retinal degeneration, chorioretinal scar of indeterminate etiology, age related macular degeneration, central retinal artery occlusion, macular hole
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Table 6
Risk Factors for Visual Impairment in the Tema Eye Survey (N = 371)
Risk Indicator
Univariate Multivariate
Odds Ratio (95% CI) P value Odds Ratio (95% CI) P value
Age (years)
40–49 Reference <0.001 Reference <0.0001
50–59 2.67 (1.73–4.12) 2.53 (1.62–3.97)
60–69 10.04 (6.75–14.94) 9.10 (6.01–13.80)
70–79 31.37 (20.96–46.94) 28.09 (18.33–43.06)
≥80 78.88 (49.00–126.98) 66.58 (39.79–111.39)
Gender 0.941
Female Reference 0.420
Male 0.92 (0.74 – 1.14)
Marital Status
Married Reference <0.0001 Reference <0.0001
Single 1.10 (1.51–2.39) 1.97 (0.86–4.48)
Widowed 4.79 (3.78–6.08) 1.81 (1.38–2.38)
Divorced 1.72 (1.22–2.42) 1.43 (0.99–2.07)
History of Ocular Disease 1.28 (1.02–1.60) 0.03 0.1
History of Hypertension




No Reference <0.01 0.32
Yes 2.14 (1.38–3.31)
Unknown 1.26 (1.00–1.61)
N - Number of Subjects; CI - Confidence Interval
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Table 7
Risk Factors for Blindness in the Tema Eye Survey (N = 46)
Risk Indicator
Univariate Multivariate
Odds Ratio (95% CI) P value Odds Ratio (95% CI) P value
Age (years)
40–49 Reference <0.001 Reference <0.0001
50–59 1.64 (0.48–5.67) 1.66 (0.48–5.7)
60–69 7.32 (2.57–20.86) 6.68 (2.31–19.29)
70–79 14.86 (5.14–43.01) 14.66 (5.06–42.49)
≥80 49.36 (17.35–140.44) 43.68 (15.10–126.32)
Gender
Female Reference 0.70 0.90
Male 0.89 (0.49–1.62)
Marital Status




History of Ocular Disease 1.28 (1.02–1.60) 0.03 2.76 (1.50–5.07) 0.001
History of Hypertension




No Reference 0.77 0.81
Yes 1.42 (0.41–4.92)
Unknown 0.92 (0.49–1.73)
N - Number of Subjects; CI - Confidence Interval
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